2013-04-23 14:30:02 UTC

Levels of Anti-tTG During Pregnancy Are Associated with Reduced Fetal and Birth Weight

April 25, 2013

Jessica C. Kiefte–de Jong and colleagues report in Gastroenterology that high levels of antibodies against tissue transglutaminase (anti-tTG), a marker of celiac disease, during pregnancy cause reduced fetal weight and birth weight. Results were intensified for those carrying HLA-DQ2 and HLA-DQ8.

Celiac disease in pregnant women has been associated with poor growth of the fetus, but little is known about how the level of celiac disease affects fetal growth or birth outcomes. Jessica C. Kiefte–de Jong and colleagues assessed the associations between levels of antibodies against tissue transglutaminase (anti-tTG), a marker of celiac disease, and fetal growth and birth outcomes for pregnant women. Publishing in Gastroenterology, the researchers conclude that levels of anti-tTG in pregnant women are inversely associated with fetal growth. Growth was reduced to the greatest extent in fetuses of women with the highest levels of anti-tTG (>6 U/mL). Birth weight was also reduced in women with intermediate levels of anti-tTG (0.8 to ≤6 U/mL) and further reduced in those carrying HLA-DQ2 and HLA-DQ8.

Gastroenterology 2013: 144(4), 726-735.e2

More on Celiac Disease

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Avoidance of Cow's Milk–Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial

Oct. 1, 2017

Increased cow's milk antibody titers before the appearance of anti-TG2A and celiac disease indicates that subjects with celiac disease might have increased intestinal permeability in early life.

Can You Name the Top Five Products with Gluten?

Sept. 20, 2017

This month’s CGH patient education section provides you with top talking points for your celiac disease patients.